Summary: For patients  undergoing elective cardiac surgery, avoiding adding peri-operative rosuvastatin may be associated with a lower likelihood of postoperative acute kidney injury, without affecting the risk of postoperative atrial fibrillation or perioperative myocardial damage, compared to adding rosuvastatin perioperatively.

http://www.ncbi.nlm.nih.gov/m/pubmed/27144849/

Strength of Recommendation = B

Advertisements